These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 402686)
21. [Effects of Angelica sinensis polysaccharides on hepatic drug metabolism enzymes activities in mice]. Xia XY; Peng RX; Kong R; Yang ZQ; Chen X Zhongguo Zhong Yao Za Zhi; 2003 Feb; 28(2):149-52. PubMed ID: 15015291 [TBL] [Abstract][Full Text] [Related]
22. Prevention of acetaminophen-induced hepatotoxicity by dimethyl sulfoxide. Park Y; Smith RD; Combs AB; Kehrer JP Toxicology; 1988 Nov; 52(1-2):165-75. PubMed ID: 3188030 [TBL] [Abstract][Full Text] [Related]
23. The effect of some inducers of hepatic xenobiotic-metabolizing enzymes on the urinary excretion of D-glucuronic acid metabolites in the rat. Lake BG; Longland RC; Hodgson RA; Severn BJ; Gangolli SD; Lloyd AG Biochem Soc Trans; 1975; 3(1):188-91. PubMed ID: 805065 [No Abstract] [Full Text] [Related]
24. Activities of mixed function oxidases, UDP-glucuronyl transferase and sulphate conjugation enzymes in galliformes and anseriformes. Bartlet AL; Kirinya LM Q J Exp Physiol Cogn Med Sci; 1976 Apr; 61(2):105-19. PubMed ID: 819957 [TBL] [Abstract][Full Text] [Related]
25. Acute toxicity of substrates of the mixed function oxidase system in normal and phenobarbital-pretreated mice. Litterst CL; Mimnaugh EG; Gram TE; Guarino AM; Simon RC J Toxicol Environ Health; 1975 Sep; 1(1):39-46. PubMed ID: 810600 [No Abstract] [Full Text] [Related]
26. Effect of alpha-pinene on the mixed function microsomal oxidase system in the rat. Pap A; Szarvas F Acta Med Acad Sci Hung; 1976; 33(4):379-85. PubMed ID: 1032243 [TBL] [Abstract][Full Text] [Related]
27. [Effect of Schistosoma japonicum infection on liver drug-metabolizing enzymes of mice]. Wang J; Qiu ZY; Xie W; Wu YY Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1993; 11(1):9-11. PubMed ID: 8403284 [TBL] [Abstract][Full Text] [Related]
28. Protection by Osbeckia aspera against carbon tetrachloride-mediated alterations in microsomal drug metabolizing enzyme activity. Jayatilaka KA; Thabrew MI J Pharm Pharmacol; 2000 Apr; 52(4):461-5. PubMed ID: 10813559 [TBL] [Abstract][Full Text] [Related]
29. Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice. Cha YN; Edwards R J Pharmacol Exp Ther; 1976 Nov; 199(2):432-40. PubMed ID: 185361 [TBL] [Abstract][Full Text] [Related]
30. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease. Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397 [TBL] [Abstract][Full Text] [Related]
31. Effect of sulfamethazine on mixed function oxidase in chickens. Kodam KM; Govindwar SP Vet Hum Toxicol; 1995 Aug; 37(4):340-2. PubMed ID: 8540224 [TBL] [Abstract][Full Text] [Related]
32. Biochemical properties of some microsomal xenobiotic-metabolizing enzymes in rabbit small intestine. Chhabra RS; Fouts JR Drug Metab Dispos; 1976; 4(3):208-14. PubMed ID: 6224 [TBL] [Abstract][Full Text] [Related]
33. [Effect of cadmium on the microsomal liver enzymes of the rat]. Ozierenski B; Plass R; Lewerenz HJ Arch Exp Veterinarmed; 1980; 34(3):417-24. PubMed ID: 7436673 [TBL] [Abstract][Full Text] [Related]
34. [Effect of benzodiazepines on drug-metabolizing enzymes. II. Increased environmental temperature as a modifier of the effect of nitrazepam on microsomal monooxygenases of the rat liver]. Pachecka J; KobyliĆska K; Brozyna M; Bicz W Acta Pol Pharm; 1988; 45(3):271-5. PubMed ID: 3239430 [No Abstract] [Full Text] [Related]
35. Induction of cytochrome P-450 and related drug-oxidizing activities in muscone (3-methylcyclopentadecanone)-treated rats. Tanaka E; Kurata N; Kohno M; Yoshida T; Kuroiwa Y Biochem Pharmacol; 1987 Dec; 36(24):4263-7. PubMed ID: 3689452 [TBL] [Abstract][Full Text] [Related]
36. Induction of hepatic enzymes by methaqualone and effect on warfarin-induced hypoprothrombinemia. Mathur PP; Smyth RD; Herczeg T; Reavey-Cantwell NH J Pharmacol Exp Ther; 1976 Jan; 196(1):204-12. PubMed ID: 1246011 [TBL] [Abstract][Full Text] [Related]
37. Cadmium administration and hepatic drug metabolizing enzyme system: effect of pretreatment with phenobarbital and 3-methyl cholanthrene. Mgbodile MU Biochem Int; 1983 Jan; 6(1):11-20. PubMed ID: 6679315 [TBL] [Abstract][Full Text] [Related]
38. Role of neonatal androgen in the development of hepatic microsomal drug-metabolizing enzymes. Chung LW; Raymond G; Fox S J Pharmacol Exp Ther; 1975 May; 193(2):621-30. PubMed ID: 1142108 [TBL] [Abstract][Full Text] [Related]
39. Comparison of in vitro drug metabolism by lung, liver, and kidney of several common laboratory species. Litterst CL; Mimnaugh EG; Reagan RL; Gram TE Drug Metab Dispos; 1975; 3(4):259-65. PubMed ID: 240655 [TBL] [Abstract][Full Text] [Related]
40. [Effect of thiamine on the activity of liver endoplasmic reticulum enzymes metabolizing drugs]. Sushko LI; Lukienko PI Farmakol Toksikol; 1979; 42(1):56-9. PubMed ID: 421893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]